Jeffrey Fink - May 10, 2023 Form 4 Insider Report for Lipocine Inc. (LPCN)

Role
Director
Signature
/s/ Jeffrey Fink
Stock symbol
LPCN
Transactions as of
May 10, 2023
Transactions value $
$7,968
Form type
4
Date filed
5/12/2023, 04:33 PM
Previous filing
Jun 10, 2022
Next filing
Jun 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Common Stock (Right to Buy) Award $7.97K +30K +22.06% $0.27 166K May 10, 2023 Common Stock 30K $0.27 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

1. 100% vesting one year from date of grant.